11,771
Total Claims
$2.9M
Drug Cost
2,565
Beneficiaries
$1,116
Cost/Patient
Peer Comparison vs. 218,535 Nurse Practitioner providers
-5%
Cost per patient vs peers
$1,116 vs $1,174 avg
+109%
Brand preference vs peers
18.5% vs 8.9% avg
Brand vs Generic
82% generic
Brand: 2,176 claims · $2.6M
Generic: 9,595 claims · $238K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,001 | $1.3M |
| Rivaroxaban | 298 | $391K |
| Sacubitril/Valsartan | 255 | $378K |
| Empagliflozin | 189 | $270K |
| Ticagrelor | 109 | $90K |
| Dapagliflozin Propanediol | 58 | $82K |
| Evolocumab | 39 | $47K |
| Metoprolol Succinate | 1,538 | $38K |
| Dronedarone Hcl | 16 | $34K |
| Atorvastatin Calcium | 1,161 | $24K |
| Rosuvastatin Calcium | 558 | $23K |
| Evolocumab | 22 | $21K |
| Alirocumab | 11 | $17K |
| Losartan Potassium | 568 | $9,370 |
| Ranolazine | 37 | $7,885 |
Prescribing Profile
56
Unique Drugs
$2.4M
Patient Profile
76
Avg Age
47%
Female
1.51
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data